2023 Q2 Form 10-Q Financial Statement

#000155837023007024 Filed on April 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $5.119B $4.892B
YoY Change 1.83% 4.96%
Cost Of Revenue $2.682B $3.086B
YoY Change -14.64% 6.3%
Gross Profit $2.437B $1.806B
YoY Change 29.28% 2.73%
Gross Profit Margin 47.61% 36.92%
Selling, General & Admin $971.0M $476.0M
YoY Change 99.38% -3.05%
% of Gross Profit 39.84% 26.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $521.0M $505.0M
YoY Change 2.56% 4.77%
% of Gross Profit 21.38% 27.96%
Operating Expenses $1.492B $476.0M
YoY Change 206.37% -3.05%
Operating Profit $945.0M $825.0M
YoY Change 6.18% 7.42%
Interest Expense -$137.0M -$120.0M
YoY Change 47.31% 41.18%
% of Operating Profit -14.5% -14.55%
Other Income/Expense, Net $2.000M $2.000M
YoY Change -150.0% -33.33%
Pretax Income $809.0M $696.0M
YoY Change 4.25% 3.73%
Income Tax $196.0M $164.0M
% Of Pretax Income 24.23% 23.56%
Net Earnings $615.0M $533.0M
YoY Change 4.77% 3.9%
Net Earnings / Revenue 12.01% 10.9%
Basic Earnings Per Share $1.52 $1.31
Diluted Earnings Per Share $1.51 $1.30
COMMON SHARES
Basic Shares Outstanding 406.8M 408.2M
Diluted Shares Outstanding 407.7M 409.0M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $144.0M $257.0M
YoY Change -83.89% 65.81%
Cash & Equivalents $144.0M $257.0M
Short-Term Investments
Other Short-Term Assets $320.0M $336.0M
YoY Change 18.96% 21.74%
Inventory $170.0M $170.0M
Prepaid Expenses
Receivables $2.576B $2.418B
Other Receivables $270.0M $190.0M
Total Short-Term Assets $3.480B $3.371B
YoY Change -12.72% 10.2%
LONG-TERM ASSETS
Property, Plant & Equipment $15.92B $15.71B
YoY Change 10.67% 9.84%
Goodwill $9.399B $9.344B
YoY Change 4.18% 3.43%
Intangibles $809.0M $823.0M
YoY Change -3.0% -5.18%
Long-Term Investments $564.0M $569.0M
YoY Change -7.08% -8.96%
Other Assets $1.445B $1.002B
YoY Change 60.73% 12.21%
Total Long-Term Assets $28.13B $27.92B
YoY Change 7.62% 6.72%
TOTAL ASSETS
Total Short-Term Assets $3.480B $3.371B
Total Long-Term Assets $28.13B $27.92B
Total Assets $31.61B $31.29B
YoY Change 4.93% 7.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.626B $1.510B
YoY Change 17.66% 9.1%
Accrued Expenses $1.544B $1.426B
YoY Change 3.42% 2.81%
Deferred Revenue $568.0M $584.0M
YoY Change -7.79% -2.67%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $513.0M $336.0M
YoY Change 122.08% -22.76%
Total Short-Term Liabilities $4.251B $3.856B
YoY Change 14.21% 1.31%
LONG-TERM LIABILITIES
Long-Term Debt $14.86B $15.03B
YoY Change 5.76% 15.19%
Other Long-Term Liabilities $3.802B $1.079B
YoY Change 242.52% -4.17%
Total Long-Term Liabilities $18.66B $1.079B
YoY Change 1580.81% -4.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.251B $3.856B
Total Long-Term Liabilities $18.66B $1.079B
Total Liabilities $24.71B $24.48B
YoY Change 7.71% 10.91%
SHAREHOLDERS EQUITY
Retained Earnings $13.74B $13.41B
YoY Change 9.4% 9.53%
Common Stock $5.347B $5.250B
YoY Change 1.6% 1.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.909B $6.794B
YoY Change
Total Liabilities & Shareholders Equity $31.61B $31.29B
YoY Change 4.93% 7.09%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $615.0M $533.0M
YoY Change 4.77% 3.9%
Depreciation, Depletion And Amortization $521.0M $505.0M
YoY Change 2.56% 4.77%
Cash From Operating Activities $1.030B $1.040B
YoY Change -1.62% -17.33%
INVESTING ACTIVITIES
Capital Expenditures $520.0M $660.0M
YoY Change -194.55% -257.89%
Acquisitions $34.00M
YoY Change 277.78%
Other Investing Activities -$41.00M $95.00M
YoY Change -286.36% -36.67%
Cash From Investing Activities -$561.0M -$778.0M
YoY Change 6.25% 36.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -600.0M -319.0M
YoY Change -363.16% -49.76%
NET CHANGE
Cash From Operating Activities 1.030B 1.040B
Cash From Investing Activities -561.0M -778.0M
Cash From Financing Activities -600.0M -319.0M
Net Change In Cash -131.0M -53.00M
YoY Change -117.54% -201.92%
FREE CASH FLOW
Cash From Operating Activities $1.030B $1.040B
Capital Expenditures $520.0M $660.0M
Free Cash Flow $510.0M $380.0M
YoY Change -68.07% -77.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsCurrent
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssetsCurrent
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#RestrictedCashAndInvestmentsNoncurrent
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsNoncurrentAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#RestrictedCashAndInvestmentsNoncurrent
CY2022Q4 us-gaap Environmental Loss Contingency Current Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2023Q1 us-gaap Environmental Loss Contingency Current Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q4 us-gaap Environmental Loss Contingency Noncurrent Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#AccruedCappingClosurePostClosureAndEnvironmentalCostsNoncurrent
CY2023Q1 us-gaap Environmental Loss Contingency Noncurrent Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#AccruedCappingClosurePostClosureAndEnvironmentalCostsNoncurrent
CY2022Q4 us-gaap Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#AccruedCappingClosurePostClosureAndEnvironmentalCostsNoncurrent http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2023Q1 us-gaap Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#AccruedCappingClosurePostClosureAndEnvironmentalCostsNoncurrent http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000823768
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-12154
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Waste Management, Inc
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
73-1309529
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
800 Capitol Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 3000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1766000000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1426000000
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
CY2023Q1 dei City Area Code
CityAreaCode
713
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
512-6200
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q1 dei Trading Symbol
TradingSymbol
WM
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
406816705
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
257000000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
351000000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26000000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2418000000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2461000000
CY2023Q1 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
5000000
CY2022Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
7000000
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
190000000
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
291000000
CY2023Q1 us-gaap Supplies
Supplies
170000000
CY2022Q4 us-gaap Supplies
Supplies
164000000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
336000000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
284000000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3371000000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3551000000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22027000000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21627000000
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
15705000000
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
15719000000
CY2023Q1 us-gaap Goodwill
Goodwill
9344000000
CY2022Q4 us-gaap Goodwill
Goodwill
9323000000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
823000000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
827000000
CY2023Q1 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
476000000
CY2022Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
348000000
CY2023Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
569000000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
578000000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1002000000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1021000000
CY2023Q1 us-gaap Assets
Assets
31290000000
CY2022Q4 us-gaap Assets
Assets
31367000000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1510000000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1625000000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
584000000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
589000000
CY2023Q1 us-gaap Debt Current
DebtCurrent
336000000
CY2022Q4 us-gaap Debt Current
DebtCurrent
414000000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3856000000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4394000000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
15034000000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14570000000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1784000000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1733000000
CY2023Q1 us-gaap Accrued Capping Closure Post Closure And Environmental Costs Noncurrent
AccruedCappingClosurePostClosureAndEnvironmentalCostsNoncurrent
2729000000
CY2022Q4 us-gaap Accrued Capping Closure Post Closure And Environmental Costs Noncurrent
AccruedCappingClosurePostClosureAndEnvironmentalCostsNoncurrent
2700000000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1079000000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1106000000
CY2023Q1 us-gaap Liabilities
Liabilities
24482000000
CY2022Q4 us-gaap Liabilities
Liabilities
24503000000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
630282461
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
630282461
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
6000000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6000000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5244000000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5314000000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13414000000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13167000000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-57000000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-69000000
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
223491127
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
222396166
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
11813000000
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
11569000000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
6794000000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6849000000
CY2023Q1 us-gaap Minority Interest
MinorityInterest
14000000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
15000000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6808000000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6864000000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31290000000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31367000000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4892000000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4661000000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3086000000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2903000000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
476000000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
491000000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
505000000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
482000000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
482000000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
42000000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11000000
CY2023Q1 us-gaap Restructuring Charges
RestructuringCharges
3000000
CY2023Q1 wm Gain Loss From Divestitures Asset Impairments And Unusual Items
GainLossFromDivestituresAssetImpairmentsAndUnusualItems
-3000000
CY2022Q1 wm Gain Loss From Divestitures Asset Impairments And Unusual Items
GainLossFromDivestituresAssetImpairmentsAndUnusualItems
17000000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
4067000000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
3893000000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
825000000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
768000000
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-120000000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-85000000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-11000000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-15000000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000000
CY2023Q1 wm Interest And Other Income Expense
InterestAndOtherIncomeExpense
-129000000
CY2022Q1 wm Interest And Other Income Expense
InterestAndOtherIncomeExpense
-97000000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
696000000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
671000000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
164000000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
157000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
532000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
514000000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
533000000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
513000000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.31
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.24
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.30
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
CY2023Q1 us-gaap Profit Loss
ProfitLoss
532000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
514000000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
5000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1000000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
5000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-13000000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10000000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
544000000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
512000000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
545000000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
511000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
532000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
514000000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
505000000
CY2023Q1 us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
32000000
CY2022Q1 us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
28000000
CY2023Q1 wm Provision For Doubtful Accounts And Other Credit Losses
ProvisionForDoubtfulAccountsAndOtherCreditLosses
9000000
CY2022Q1 wm Provision For Doubtful Accounts And Other Credit Losses
ProvisionForDoubtfulAccountsAndOtherCreditLosses
10000000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
26000000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25000000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
10000000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4000000
CY2023Q1 wm Gain Loss From Divestitures Asset Impairments And Other Noncash Portion
GainLossFromDivestituresAssetImpairmentsAndOtherNoncashPortion
-3000000
CY2022Q1 wm Gain Loss From Divestitures Asset Impairments And Other Noncash Portion
GainLossFromDivestituresAssetImpairmentsAndOtherNoncashPortion
17000000
CY2023Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-11000000
CY2022Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-15000000
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-138000000
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-93000000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
51000000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
20000000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-22000000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-19000000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-145000000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
101000000
CY2023Q1 wm Increase Decrease In Deferred Revenue And Other Operating Liabilities
IncreaseDecreaseInDeferredRevenueAndOtherOperatingLiabilities
-64000000
CY2022Q1 wm Increase Decrease In Deferred Revenue And Other Operating Liabilities
IncreaseDecreaseInDeferredRevenueAndOtherOperatingLiabilities
-11000000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1044000000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1258000000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
34000000
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9000000
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
660000000
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
418000000
CY2023Q1 wm Proceeds From Divestiture Of Businesses Net Of Cash Divested And Proceeds From Sales Of Assets Investing Activities
ProceedsFromDivestitureOfBusinessesNetOfCashDivestedAndProceedsFromSalesOfAssetsInvestingActivities
11000000
CY2022Q1 wm Proceeds From Divestiture Of Businesses Net Of Cash Divested And Proceeds From Sales Of Assets Investing Activities
ProceedsFromDivestitureOfBusinessesNetOfCashDivestedAndProceedsFromSalesOfAssetsInvestingActivities
5000000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
95000000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
150000000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-778000000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-572000000
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
6885000000
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
2362000000
CY2023Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
6548000000
CY2022Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2471000000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
350000000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
250000000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
289000000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
275000000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12000000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
28000000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
34000000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
24000000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-319000000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-635000000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1000000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-53000000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
52000000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
445000000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
194000000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
392000000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246000000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
257000000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155000000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
62000000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
20000000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
73000000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
71000000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
392000000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246000000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6864000000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
532000000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12000000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.70
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
289000000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
42000000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
353000000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6808000000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7126000000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
514000000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.65
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
275000000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
34000000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
250000000
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
1000000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7146000000
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
192000000
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt 0pt 12pt 7.2pt;"><span style="font-style:italic;font-weight:bold;">Concentrations of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments held within restricted funds, and accounts receivable. We make efforts to control our exposure to credit risk associated with these instruments by (i) placing our assets and other financial interests with a diverse group of credit-worthy financial institutions; (ii) holding high-quality financial instruments while limiting investments in any one instrument and (iii) maintaining strict policies over credit extension that include credit evaluations, credit limits and monitoring procedures, although generally we do not have collateral requirements for credit extensions. We also control our exposure associated with trade receivables by discontinuing service, to the extent allowable, to non-paying customers. However, our overall credit risk associated with trade receivables is limited due to the large number and diversity of customers we serve.</p>
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 7.2pt;">Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">When necessary, reclassifications have been made to our prior period financial information to conform to the current year presentation and are not material to our consolidated financial statements. </p>
CY2023Q1 us-gaap Accrued Capping Closure Post Closure And Environmental Costs
AccruedCappingClosurePostClosureAndEnvironmentalCosts
168000000
CY2022Q4 us-gaap Accrued Capping Closure Post Closure And Environmental Costs
AccruedCappingClosurePostClosureAndEnvironmentalCosts
168000000
CY2023Q1 us-gaap Accrued Capping Closure Post Closure And Environmental Costs Noncurrent
AccruedCappingClosurePostClosureAndEnvironmentalCostsNoncurrent
2729000000
CY2022Q4 us-gaap Accrued Capping Closure Post Closure And Environmental Costs Noncurrent
AccruedCappingClosurePostClosureAndEnvironmentalCostsNoncurrent
2700000000
CY2023Q1 wm Accrued Capping And Environmental Costs
AccruedCappingAndEnvironmentalCosts
2897000000
CY2022Q4 wm Accrued Capping And Environmental Costs
AccruedCappingAndEnvironmentalCosts
2868000000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
91000000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
88000000
CY2023Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
15370000000
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
14984000000
CY2023Q1 us-gaap Debt Current
DebtCurrent
336000000
CY2022Q4 us-gaap Debt Current
DebtCurrent
414000000
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
15034000000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14570000000
CY2023Q1 wm Debt And Financing Leases Maturing Or Subject To Remarketing Within Next Twelve Months
DebtAndFinancingLeasesMaturingOrSubjectToRemarketingWithinNextTwelveMonths
2300000000
CY2023Q1 wm Debt Maturing Or Subject To Refinancing Within Next Twelve Months Classified As Long Term
DebtMaturingOrSubjectToRefinancingWithinNextTwelveMonthsClassifiedAsLongTerm
1900000000
CY2023Q1 us-gaap Debt Current
DebtCurrent
336000000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1040000000.00
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.236
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.235
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7000000
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
10000000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3000000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
406800000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
415200000
CY2023Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
600000
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
500000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
407400000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
415700000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1600000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2100000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
409000000.0
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
417800000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
5600000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
5900000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1800000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1800000
CY2023Q1 wm Number Of Landfills Adjacent To Or Near Homeowners Properties With Agreements Guaranteeing Market Value
NumberOfLandfillsAdjacentToOrNearHomeownersPropertiesWithAgreementsGuaranteeingMarketValue
17
CY2023Q1 wm Environmental Remediation Reasonably Possible Additional Losses High Estimate
EnvironmentalRemediationReasonablyPossibleAdditionalLossesHighEstimate
130000000
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
200000000
CY2023Q1 wm Number Of Sites Listed On Environmental Protection Agency National Priorities List For Which We Have Been Notified We Are Prp
NumberOfSitesListedOnEnvironmentalProtectionAgencyNationalPrioritiesListForWhichWeHaveBeenNotifiedWeArePrp
73
CY2023Q1 wm Number Of Sites Listed On Environmental Protection Agency National Priorities List For Which We Have Been Notified We Are Prp
NumberOfSitesListedOnEnvironmentalProtectionAgencyNationalPrioritiesListForWhichWeHaveBeenNotifiedWeArePrp
73
CY2023Q1 wm Number Of Owned Sites Listed On Environmental Protection Agency National Priorities List For Which We Have Been Notified We Are Prp
NumberOfOwnedSitesListedOnEnvironmentalProtectionAgencyNationalPrioritiesListForWhichWeHaveBeenNotifiedWeArePrp
14
CY2023Q1 wm Number Of Non Owned Sites Listed On Environmental Protection Agency National Priorities List For Which We Have Been Notified We Are Prp
NumberOfNonOwnedSitesListedOnEnvironmentalProtectionAgencyNationalPrioritiesListForWhichWeHaveBeenNotifiedWeArePrp
59
CY2023Q1 wm Disclosure Required Under Item One Zero Three Of Secs Regulation Sk
DisclosureRequiredUnderItemOneZeroThreeOfSecsRegulationSk
1000000
CY2023Q1 wm Multiemployer Plans Collective Bargaining Arrangement Percentage Of Participant
MultiemployerPlansCollectiveBargainingArrangementPercentageOfParticipant
0.20
CY2023Q1 wm Maximum Number Of Life Expected For Irs Audits To Be Completed
MaximumNumberOfLifeExpectedForIrsAuditsToBeCompleted
P24M
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4892000000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4892000000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
825000000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4661000000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4661000000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
768000000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4892000000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4661000000
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1150000000
CY2023Q1 us-gaap Proceeds From Repayments Of Long Term Debt And Capital Securities
ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
337000000

Files In Submission

Name View Source Status
wm-20230331_cal.xml Edgar Link unprocessable
0001558370-23-007024-index-headers.html Edgar Link pending
0001558370-23-007024-index.html Edgar Link pending
0001558370-23-007024.txt Edgar Link pending
0001558370-23-007024-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wm-20230331.xsd Edgar Link pending
wm-20230331x10q.htm Edgar Link pending
wm-20230331xex22d1.htm Edgar Link pending
wm-20230331xex31d1.htm Edgar Link pending
wm-20230331xex31d2.htm Edgar Link pending
wm-20230331xex32d1.htm Edgar Link pending
wm-20230331xex32d2.htm Edgar Link pending
wm-20230331xex4d1.htm Edgar Link pending
wm-20230331xex4d2.htm Edgar Link pending
wm-20230331xex4d3.htm Edgar Link pending
wm-20230331xex4d4.htm Edgar Link pending
wm-20230331xex95.htm Edgar Link pending
wm-20230331_def.xml Edgar Link unprocessable
wm-20230331_lab.xml Edgar Link unprocessable
wm-20230331x10q_htm.xml Edgar Link completed
wm-20230331_pre.xml Edgar Link unprocessable